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Background: The consumption of partially hydrogenated vegetable oils (PHVOs) high in trans fat is associated with
an increased risk of cardiovascular disease and other non-communicable diseases. In response to high intakes of
PHVOs, the Indian government has proposed regulation to set limits on the amount of trans fat permissible in
PHVOs. Global recommendations are to replace PHVOs with polyunsaturated fatty acids (PUFAs) in order to optimise
health benefits; however, little is known about the practicalities of implementation in low-income settings. The aim
of this study was to examine the technical and economic feasibility of reducing trans fat in PHVOs and reformulating it
using healthier fats.
Methods: Thirteen semi-structured interviews were conducted with manufacturers and technical experts of PHVOs in
India. Data were open-coded and organised according to key themes.
Results: Interviewees indicated that reformulating PHVOs was both economically and technically feasible provided that
trans fat regulation takes account of the food technology challenges associated with product reformulation. However,
there will be challenges in maintaining the physical properties that consumers prefer while reducing the trans fat in
PHVOs. The availability of input oils was not seen to be a problem because of the low cost and high availability of
imported palm oil, which was the input oil of choice for industry. Most interviewees were not concerned about the
potential increase in saturated fat associated with increased use of palm oil and were not planning to use PUFAs in
product reformulation. Interviewees indicated that many smaller manufacturers would not have sufficient capacity to
reformulate products to reduce trans fat.
Conclusions: Reformulating PHVOs to reduce trans fat in India is feasible; however, a collision course exists where the
public health goal to replace PHVOs with PUFA are opposed to the goals of industry to produce a cheap alternative
product that meets consumer preferences. Ensuring that product reformulation is done in a way that maximises health
benefits will require shifts in knowledge and subsequent demand of products, decreased reliance on palm oil,
investment in research and development and increased capacity for smaller manufacturers.
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The consumption of industrially produced trans fatty
acids (TFA) is associated with an increased risk of non-
communicable diseases (NCDs), especially cardiovascular
disease (CVD) [1-4]. As part of the Global Monitoring
Framework for NCDs, the World Health Organization
(WHO) has recommended TFA elimination from the
diet [5] and has called for “national policies that virtu-
ally eliminate partially hydrogenated vegetable oils (PHVOs)
in the food supply and replace [them] with polyunsatur-
ated fatty acids (PUFA)” [6]. However, little is known about
the practicalities of implementing these global recommen-
dations and whether or not low and middle-income coun-
tries will have the capacity to reformulate their products
in a way that maximises health gains.
In India, PHVOs are consumed principally through
vanaspati, a vegetable ghee used as cooking oil and in
fried snacks, baked goods and street vendor foods [7].
Vanaspati is popular because it is a cheap and stable
energy source with a long shelf life that withstands
repeated heating. These properties make it an attractive
product for commercial baking and frying [7,8]. In re-
sponse to the high levels of TFA in Indian PHVOs
(vanaspati and bakery shortening), the Food Safety and
Standards Authority of India (FSSAI), under the Ministry
of Health and Family Welfare, has proposed regulation
that includes setting an upper limit of 10% (by weight)
TFA in PHVOs reducing to 5% over three years [9]. The
proposed limits will target PHVOs rather than the foods
that contain them.
At the moment, there are four regulations that may
limit industry’s ability to reformulate PHVOs to meet
the aforementioned TFA limits: 1) the melting point cap
of 41°C, 2) the classification of palm stearin as an ined-
ible oil, 3) the permitted use of only two different oils in
vanaspati and 4) the inability to use interesterification.
The melting point cap and the inability to use palm
stearin in food products was based on the belief that
humans could not easily digest oils with melting points
higher than body temperature; however, scientific evi-
dence refutes this assertion [10]. Moreover, interesterifi-
cation and the use of more than two oils were not
permitted under the Prevention of Food Adulteration
Act (now the Food Safety and Standard Act). Consulta-
tions with FSSAI, scientific experts and industry were
held in 2010 at the National Institute of Nutrition to
discuss the proposed TFA regulation in India. The rec-
ommendations from that committee were to remove the
aforementioned regulatory barriers to facilitate product
reformulation.
Although previous regulation dictated that 25% of the
input oil used in PHVOs be indigenous sources, in 2003
this was removed leading to a shift from domestically
produced oils that were high in mono-unsaturated fattyacids (MUFA) and PUFA to palm oil [7]. Because of the
high saturated fatty acid (SFA) content of palm oil it is
semi-solid at room temperature thereby requiring less
hydrogenation to ensure the product texture preferred
by consumers [10]. As part of the FSSAI consultation
process, the vanaspati industry commissioned a study
by Frost & Sullivan showing the relationship between
melting point and TFA concentration – as the hydro-
genation process proceeds TFA content first increases
and then decreases as the melting point is increased
[10]. In this report they show that with an increase in
the melting point to 47-48°C, the TFA content of PHVOs
with palm oil as the main ingredient will decrease to 15%
whereas for soybean oil the TFA content would decrease
to 36% - suggesting that the higher the content of SFA
in the input oil, the lower the degree of hydrogenation
required and the lower the TFA levels to get the desired
texture [11].
Trans fat regulation has been effective in high-income
countries and many products have been reformulated
without substantially increasing saturated fatty acids (SFA)
[12-15] – through use of trait-enhanced oils, interesterifi-
cation, fractionation and blending [16-18] – it is not
known whether industry in low and middle-income
countries, such as India, will be able to use the same
approaches. Industry might simply shift from PHVOs
to high SFA fats such as palm oil or increase the degree
of hydrogenation of native oils – partial hydrogenation
of oils turns the cis-unsaturated fatty acids (MUFA and
PUFA) into trans-unsaturated fatty acids, but full hydro-
genation turns all unsaturated fatty acids (the original
cis and the intermediate trans fatty acids) into SFA. This
would decrease the TFA but increase the SFA content
of vanaspati. Other methods might be used to reduce
TFA while limiting the increase in SFA. Trait-enhanced
oils (i.e., high-oleic sunflower oil) are fats modified via
selective breeding or biotechnology to increase the
oxidative stability required in frying and baking [19].
Interesterification modifies the melting point and crys-
tallisation of the fat by rearranging the fatty acids,
producing TFA free fats with desirable physical prop-
erties [19]. Fractionation involves splitting fats into their
solid components (i.e., palm stearin). The fractions can
then either be used alone or in combination with other
fats [19]. Blending interesterified oils with liquid oils high
in PUFA can result in TFA free products with relatively
low SFA levels [17]. Research has been conducted to
determine the most appropriate technologies for spe-
cific product requirements [7,18,20].
A collision course exists in India where the public
health goal to replace PHVOs with PUFA are opposed to
the goals of industry to produce a cheap alternative prod-
uct that meets consumer demands. The aim of this study
was to examine the technical and economic feasibility of
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lating it using healthier fats.
Methods
This study reports on qualitative interviews of Indian
manufacturers of vanaspati and technical experts work-
ing in an NGO and government. It is part of a larger
project that aims to examine awareness and use of TFA,
and the feasibility of its removal from the Indian food
supply from the perspectives of manufacturers, retailers
and consumers. Ethics approval for the study was ob-
tained from the University of Sydney and the Public
Health Foundationof India’s Institutional EthicsCommittees.
All interviewees providedwritten informed consent.
Semi-structured interviews were conducted with respon-
dents who had technical expertise on the use of PHVO
in the Indian food industry. Industry interviewees were
either the Technical or Research and Development
Directors of the companies. Study participants were
recruited using purposive sampling. To provide a variety
of perspectives, representatives of manufacturing compan-
ies of varying sizes (including multinationals and smaller
companies) were included. All potential interviewees
were first contacted via telephone. Initial interviewees
were identified by one of the researchers, and subse-
quent interviewees were recruited using chain of referral
snowball sampling [21]. In addition, to identify inter-
viewees from smaller regional companies, potential par-
ticipants were contacted from a list of all the Indian
vanaspati manufacturers; the list was obtained from the
Indian Vanaspati Producers’Association. Of the 79 manu-
facturers contacted, we were unable to make contact with
30 (mainly due to incorrect contact information) and 15
did not manufacture vanaspati. Of the remaining 34
companies, ten participated in the study; the remaining
companies either refused to participate or did not re-
turn our phone calls. Many potential participants from
smaller companies seemed suspicious of the intent of
the study and declined to participate, resulting in a
smaller than planned sample size.
Overall, ten interviews with Indian manufacturers of
PHVOs were conducted. In addition, we recruited one
person who was an oil technologist who presided over an
oil technologist non-government organisation (NGO), and
two government technocrats who work on this food policy
area at the national level. Two additional manufacturers
were interviewed but later decided to rescind consent
from the study resulting in a total of 13 interviews. Given
that the aim was to get perspectives from both smaller
and larger companies, the market share of the participat-
ing players varied. However, two of the manufacturers
with the highest market share participated in the study.
Interviews were conducted between May and August
2012 in Delhi, Mumbai, Jaipur, Rudapur and Rajpura,India. The majority of interviews were conducted face-
to-face, although four were completed via telephone
due to travel constraints around India. Two researchers
(SMD and AS) conducted all of the study interviews;
face-to-face interviews were usually conducted with
both of the interviewers present. Telephone interviews
were conducted by one of the two interviewers. The
interviewers had been previously trained in qualitative
methods and had experience conducting interviews.
Interviews averaged 40 minutes and were conducted in
English, with the exception of one that was completed
in Hindi and subsequently translated to English.
The interview was based on the technical and eco-
nomic feasibility of reducing TFA in PHVOs and re-
placing it with healthier oils (i.e., PUFAs). The interview
guide topics were based on a feasibility assessment tool
used to assess policy options to improve diets in the
Pacific Islands [22] and was adapted for the context
based on discussion with food technology experts in
India. The interview guide is reported in Table 1. Five
experts in the study area reviewed the interview guide
prior to finalising its content; however, it had not been
previously validated. Interviews were audio-recorded or
detailed notes were taken, depending on whether the
interviewee consented to being recorded. Interviews
that were audio-recorded were transcribed verbatim.
Interview transcripts and detailed notes were analysed
using NVivo software (version 9; QSR International,
Doncaster, Victoria, Australia). An inductive qualitative
analysis was conducted by SMD. Data were first open-
coded and these codes were subsequently organised
based on key themes, which were later agreed upon by
the research team.
Results
Surprisingly all interviewees indicated that TFA was
unhealthy and its consumption should be limited. How-
ever, several interviewees stated that consumption of
TFA and total fat is low and that fat consumption is not
as problematic in India as compared to other countries.
Key themes that arose in the interviews about the feasi-
bility of reducing TFA in India related to consumer
preferences, regulatory issues, the availability of oils and
both the technical and economic feasibility. Although
interviewees from government, a NGO and industry were
interviewed there were no major differences in their views
regarding the feasibility of production reformulation.
Consumer preferences
Interviewees suggested that consumers prefer vanaspati
products that are hard, white and granular (bakery shorten-
ing has the “grains” removed) although there are regional
variations in preference. These perceived preferences
were stated as one of the reasons for the challenges in
Table 1 Interview topics based on technical and economic
feasibility of reformulating partially hydrogenated
vegetable oils in India
Main topic Interview questions
Trans fat and health What is your understanding of the health issues
related to – vanaspati; - other cooking oils; -
trans fat
Company characteristics What are the main products that your
company produces?
Which of the products that your company
produces contain hydrogenated oils?
Where do you obtain your raw materials?
(which areas, types of producers)?
Trans fat regulation What do you know about the proposed trans
fat regulation?
How will the proposed trans fat regulation
affect your company? Will it affect your
profit margins?
Could the government do anything to help
(i.e., incentives, subsidies, etc.) make the
transition to low trans/trans fat free
products easier?
Feasibility How feasible is product reformulation of
vanaspati (or shortening/spreads)?
Can you comment on the:
Technological feasibility
Availability of replacement oils
Economic feasibility
What considerations will have to be made in
terms of the cultural/social acceptability of
alternative products?
What will be the main barriers or challenges
associated with product reformulation?
Costs What are the current costs associated with
the production of vanaspati?
Which additional costs will be involved in the
reformulation of vanaspati (or shortenings)?
How will these costs differ with a limit of 10%
vs 5% trans fat in PHVOs?
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would need to make a product that has a hard texture,
which remains semi-solid even in the hot temperatures
of the summer months.
Many interviewees mentioned that it is difficult to
maintain the “hardness” that consumers demand while
reducing the TFA in PHVOs. Some interviewees sug-
gested that people “need to be educated” not only about
the potential negative health effects of ‘hard’ vanaspati
products (and TFA) but also the effects of replacement
with palm stearin and its effect on SFA.
The potential for SFA to increase when TFA is re-
duced was not seen as a widespread concern by manu-
facturers. One interviewee did note that increasing use
of palm stearin would make “the saturated fat acid go upand that is not a healthy oil”, whereas others said palm
was a “healthy oil” and an “agreeable choice” for product
reformulation.
Interviewees indicated that consumers were beginning
to demand healthier products. Some interviewees noted
the potential to market healthier products to these health
conscious consumers in order to differentiate themselves
from other companies. Although some households use
vanaspati as a cooking fat, it is predominantly sold, as
several participants noted, from “business to business”
to be used as an input ingredient in processed foods. It
was suggested that since the main market for PHVOs is
other businesses, large companies could drive demand
for lower TFA products, given their “global linkages”,
thereby facilitating TFA reduction.
Regulatory issues
Overall, industry respondents were accepting of the pro-
posed national TFA regulation (particularly a 10% (by
weight) TFA limit in PHVOs), and some were even crit-
ical of the lengthy policy process. Interviewees from multi-
national companies indicated that the regulation would
lead to a more level playing field, which could potentially
benefit them. All interviewees mentioned the need to
align Indian regulation with international standards (i.e.,
CODEX). Specifically they were concerned about the
current cap on the melting point, the classification of
palm stearin as inedible oil, and the inability to use
enzymatic and chemical interesterification. However,
interviewees from both industry and government noted
that it was likely that these “archaic laws” would be re-
moved when the government enacts the proposed TFA
regulation, as suggested during consultations, given that
the melting point cap results in a reliance on use of TFA
in order to ensure product acceptability. Although palm
stearin is currently not permitted as input oil for PHVOs,
it was suggested that many companies were using it to
make a very hard product that was described as being “like
stone” or a “brick”.
There was a concern that there would be challenges
with the implementation, monitoring and compliance of
the proposed new regulation. Several interviewees stated
that companies were already “violating the norms” for
the melting point cap and palm stearin so compliance
may remain a problem in the future: “today people vio-
late and tomorrow they will violate”.
One interviewee noted the need for greater transpar-
ency and suggested publishing the results of food in-
spector monitoring of vanaspati quality in order to
empower consumers to make informed decisions. Inter-
viewees noted that although by law, their product should
be tested once per month by food inspectors, their products
are often not tested regularly. Moreover, one interviewee
indicated that there had been no reported violations of the
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with the exception of a few companies, the interviewee
suggested they were all exceeding the melting point cap
regulation. One multinational company who had been
abiding by the regulation said that they were producing
a product that was not acceptable to consumers because
they could not make it hard enough without violating
the regulation, something that they would not do given
their own company’s “ethics” leading them “to comply
with every law in the land”. Table 2 provides supporting
quotes regarding the aforementioned regulatory issues.
Replacement oils
There was consensus among interviewees that the pro-
duction of vanaspati “is primarily being driven by the
cost and the functional application of the product”.
Some interviewees described the input oils as the costli-
est component of the production process, resulting in its
selection being based on cost and availability. Palm oil is
cheaper and more widely available than the domestically
produced crops leading to industry’s increased reliance
on it. In fact, there are now special ports used by larger
companies to import palm oil. Some interviewees noted
that the companies importing crude palm oil could then
separate it into its fractions at their processing plants.
Palm stearin, a hard fraction of palm oil that is the least
costly, could then be used to improve the texture of
PHVOs – even though the government currently does
not permit its use.
One interviewee stated that the palm oil lobby pushed
TFA onto the Indian agenda. Because palm oil is semi-
solid it could replace PHVOs in some products. As in-
dustry moved towards use of palm oil as the main input
oil in vanaspati and bakery shortening, interviewees
noted that the total TFA in vanaspati decreased. When
industry was using “soft oils” as the input oils into
vanaspati they had to hydrogenate the products more to
ensure that it became the desired texture (i.e., semi-solid).
Given that palm oil is already semi-solid it does not re-
quire the same degree of hydrogenation as more liquid
vegetable oils, interviewees indicated that it has led toTable 2 Supporting quotes related to regulatory issues
for vanaspati manufacturing
Key theme Quote
Lengthy policy process “We have always seen that any regulation
change in India takes little longer and we
have…this both famous and infamous
process of far too much consultations”.
Melting point regulation “I am forced to incorporate trans [fat] into my
product…as a technical person I know that
the trans [fat] is not good and the whole
world is moving towards not having trans but
I am forced to do that”.changes in consumption patterns; palm oil and SFA
consumption are increasing and TFA consumption from
vanaspati is stabilising or even decreasing.
Most interviewees did not see the availability of alterna-
tive oils as being problematic, since they planned to con-
tinue to use palm oil as the input oil in their reformulated
products. However, one interviewee did suggest the need
to establish a supply of cheap oil for the masses that was
healthier, such as canola, and another interviewee pro-
posed the restructuring of agriculture policies to enable a
shift to oils other than palm. Supporting quotes regarding
the availability of oils are reported in Table 3.
Technological feasibility
Interviewees all agreed that the proposed TFA regulation
was both technologically and economically feasible if the
melting point regulation was removed; however, there
will be challenges in terms of creating a product that
meets consumer preferences. “I mean, this requires no
rocket science and you don’t have to reinvent the wheel,
the world has done it we can do it too, as simple as
that”. Manufacturers indicated that they could reduce
TFA in their products to 10%, given an increase in the
melting point, without having to adopt new technology.
This would entail increasing the hydrogenation of the
product, which leads to a decrease in TFA and an in-
crease in SFA. However, the larger companies mentioned
a need to invest in new equipment and research and de-
velopment to bring down the TFA to 5%, while keeping
the organoleptic properties (i.e., a product that is hard)
that consumers demand. One company indicated that
they had previously produced a vanaspati product that
was low in TFA but the product failed because the
texture was not acceptable to the consumer.
The use of full hydrogenation, interesterification, frac-
tionation and blending of soft oils with harder fraction-
ations were the main ways that manufacturers planned
to decrease TFA in their products. Interviewees often
noted that they would use these different technological
approaches in combination and based the appropriate-
ness of the different technologies on cost and perceivedTable 3 Supporting quotes relating to the replacement
oils for product reformulation
Key themes Quotes
Use of palm oil “The main raw material is 90-95% only palm oil. There
[is] no other option because indigenous oil prices are
very high”.
Palm oil import “The major players they have shifted their production
to Kandla itself, the importing place [for palm oil],
because they have got the benefit of the logistic so
they can have [a] better price, manufacturing cost
and all that”.
Table 4 Supporting quotes describing the economic
feasibility of product reformulation
Key theme Quotes
Reducing costs of vanaspati “Business is so competitive, everybody has
to be on their toes to cut down the cost”.
“People have already started using this
[palm] stearin…so the unscrupulous
people they are selling at a very low
price…we can’t play with the health of
the people so we better decide to stop
the production [of vanaspati]”.
Industry capacity “They [government] talk about trans [fat]
reducing, trans [fat] reducing, trans [fat]
reducing but…they are not looking at
the holistic picture of what it means for
the industry to cope with that”.
Compliance with regulation “If someone is not doing it…we should
not make people suffer from the health
point of view - let bigger companies start
[complying with the regulation]”.
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various pros and cons to using the different technologies
attributed to the product cost, hardness, stability and
shelf life, and potential health effects. The use of interes-
terification was identified as a way to increase the use of
“soft oils” (i.e., PUFA); however, it was noted that this
would still result in increased costs from both the use of
the technology itself and the input oils. There was dis-
agreement about whether interesterification would result
in hard enough products – some interviewees deemed
this to be problematic while others did not. In terms
of fractionation and blending, there was a concern by
a few interviewees that this would lead to overuse of
palm stearin, which would increase SFA content of food
products and negatively affect heart disease rates in the
future. However, other interviewees did not see any prob-
lem with the use of palm oil or its fractions. Enzymatic
interesterification was seen as being more appropriate
than chemical interesterification since it was believed to
be more economically feasible and used a better catalyst
as compared to chemical interesterification, which one
interviewee described as being potentially hazardous to
human health.Economic feasibility
One of the key points made by all interviewees was the
need to “minimise costs”. Interviewees consistently stated
that reducing the TFA in their products would not signifi-
cantly increase their costs and would not result in lower
profit margins. However, there were also industry players,
particularly the multinational companies, who indicated
there would be additional capital costs if they planned to
use interesterification to bring down the TFA in their
products without increasing SFA content.
Several interviewees noted a lack of capacity for smaller
sized manufacturers, leading to “hanky panky business” by
some. This lack of capacity has led multinational companies
to buy-out some of the successful smaller brands, consoli-
dating the industry, and to the closure of some vanaspati
plants. Given the lack of capacity of smaller manufacturers,
a few interviewees postulated that they would not abide by
the TFA regulation once it is implemented. However, not-
ing this should not lead to delays in the enactment of the
regulation: “Even if they [smaller companies] don’t abide by
the law it will not make much difference”, since the big
players have the majority of the market. Despite the lack of
capacity for smaller manufacturers, most of the inter-
viewees did not think that the government should provide
additional support to them to help facilitate product re-
formulation, except for a few interviews that suggested
that the government could provide subsidies, tax rebates
and/or machinery. Table 4 provides supporting quotes
regarding the economic feasibility.Discussion
This study suggests that Indian food manufacturers
and technical experts are positive about replacing TFA
in vanaspati. They believe that it is technically and
economically feasible; nevertheless, there will be chal-
lenges in meeting consumer preferences given that in-
dustry continuously strives to meet consumer demands.
Although there are currently four government regulations
relating to the melting point cap, permitted use of oils
and interesterification that will make reformulating
PHVOs difficult, it is likely that the government will
take these into account when finalising the proposed
regulation in order to reduce the product reformulation
challenges that industry will face. However, replacing
PHVOs with PUFA, as suggested by the WHO, will re-
main a challenge for Indian industry due to the increased
costs associated with using PUFAs. As yet there is not
widespread consumer knowledge in India leading to greater
demand for healthy oil products by both consumers and
businesses. It is likely that reformulation of PHVOs will
replace TFA with SFA.
Replacement oils
The removal of PHVOs from the food supply is likely to
lead to a shift in palm oil consumption [20]; this is pro-
moted by a strong palm oil lobby. Although the surge in
palm oil use has likely resulted in a decrease in TFA
levels in PHVOs such as vanaspati, SFA levels may have
increased concomitantly. As Indian industry moves to
further reduce TFA in PHVOs, it is likely that they will
continue to rely on palm oil. Although this will result in
modest improvements in heart disease risk, greater ef-
fects would be observed with replacement using PUFA
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switch cooking oil from palm to soybean oil, resulting in
a significant decrease in SFA and increase in PUFA, cor-
responding to improvements in serum total cholesterol
levels [24]. Moreover, a recent study found a link be-
tween palm oil consumption in low and middle-income
countries and increased risk of mortality due to heart
disease [25]. Other studies, including two meta-analyses,
have also found adverse effects of consuming SFA such
as palmitic acid [26-28]. Nonetheless, there continues
to be support for its use in product reformulation by
industry.
Interestingly, the French government recently proposed
setting a 300% tax on palm oil import which led to consid-
erable opposition from the Malaysian Palm Oil Council
[29]. There is an emerging trend for companies to resist
using palm oil in some high-income countries due to the
environmental and health impact of its consumption [30].
In fact, front-of-package logos indicating palm oil-free
products are now available in Europe [30]. This growing
trend may be the impetus for greater investment in alter-
natives to both PHVOs and palm oil; however, it is likely
that palm oil will continue to be used in low and middle-
income countries until consumers increase demand for
products that are both low in TFA and SFA. Because there
has been considerable interest in the environmental impact
of palm oil production [31], highlighting the environmental
as well as health concerns related to palm oil production
and consumption may get more consumer buy-in.
Although there is limited information about product
reformulation to reduce trans fat in low and middle-
income countries, a study examining industry’s response
in Latin American countries found similar challenges to
those reported in this study. For example, challenges in
the availability and cost of PUFA and concern about
consumers sensory preference for some products [32].
Ensuring that TFA reduction does not lead to an in-
crease in SFA will require active engagement and collab-
oration among the government, the agriculture sector
and Indian industry. Previous research has suggested that
leadership and commitment from senior management of
industry, collaboration across the supply chain and ad-
equate supply of alternative oils, increased demand for
healthy products, increased media coverage and regula-
tion are needed to enable healthier product reformula-
tion [18]. Currently there is insufficient demand for low
TFA and SFA products in India, which gives industry
little incentive to reformulate in a more healthful way,
especially considering the increased costs associated with
use of PUFA. Nevertheless, it is important to note that
energy intakes remain low for a significant portion of
the Indian population and food security remains a prob-
lem for many, making the need for low priced fats
essential [33].Technical feasibility
Although industry and technical experts indicated that
it was technologically feasible to reformulate PHVOs in
India to reduce TFA, they will need to invest in research
and development to reduce TFA levels to 5%. In high-
income countries, industry replaced PHVOs with dif-
ferent types of oils and fats based on the product
functionality required [7,18,20]. For example, PHVOs
for frying were often replaced with high MUFA or PUFA
liquid oils, whereas interesterification of hard fractions
with unsaturated oils has been used for solid fats such
as bakery shortening [18,20,34]. We suggest adopting a
similar approach in India; however, this will require
educating the consumers, and perhaps industry mem-
bers, about the healthiness of “soft” unsaturated oils and
strengthening supply chains to increase availability and
decrease costs of these oils. In the past, Indian industry
was required to use a proportion of domestic oil in
vanaspati production. We recommend that the govern-
ment consider re-enacting similar regulation to incentivise
the use of PUFA in product reformulation, given that
most domestically produced oils are high in these fats.
There is currently a limited supply of suitable alternative
oils to PHVOs that are low in SFA [20]; however, if the
Indian government required industry to use domestic
oils, it is likely that supply chains would be strengthened.
Economic feasibility and capacity
Multinational companies tend to have better capacity
to adopt new technology as compared to smaller manu-
facturers. Many large companies have research and
development facilities in North America or Europe, and
have already begun adopting technology such as interes-
terification in those countries. In fact, multinational
companies have developed zero TFA low SFA bakery
shortenings catering to their American and European
markets [35,36], suggesting that it is possible to bring
similar products to India. Moreover, a food technology
study conducted in Iran (where no current trans fat
regulation exists) demonstrated that low TFA vanaspati
could be produced using a combination of blending and
interesterification creating a product with reasonable SFA
levels and the same organoleptic properties demanded by
Indian consumers [37]. However, smaller companies may
not have the resources to invest in the necessary technol-
ogy to create a product that is both low in TFA and SFA.
Surprisingly, this study found little support for govern-
ment initiatives to help smaller businesses with this
process. New York City and the province of British
Columbia, Canada provided support to small businesses
to help enable the shift towards TFA free cooking oils
and fats in response to regulation in those jurisdictions
[38-40]. Moreover, in the United States, smaller com-
panies were given extra time to comply with labelling
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compared to larger companies [39]. For Indian companies
who do not have the financial means to adopt new tech-
nology, they may be forced to sell consumers a product
that is less acceptable, fail to comply with the regulation,
or sell or close their businesses. Interestingly, there was a
trend towards multinational companies purchasing the
more successful smaller PHVO businesses. One of the
potentially positive aspects of this trend is that multi-
national companies may be less likely to stray from
regulation. Therefore as more and more smaller PHVO
businesses are purchased by the larger companies, this
may help facilitate compliance with regulation and ease
the potential enforcement strains that the country may
face when the TFA regulation is enacted [8]. On the
other hand, it is important to support smaller manufac-
turers and we suggest providing incentives to help them
to better comply with regulation.
One of the main limitations of this study was the
small sample size; however, our respondents included
the companies with the highest market share for PHVOs
in India, which strengthens the transferability of the study
findings. Another limitation of this study was our use of a
non-validated interview guide. Nevertheless, we ensured
that the interview guide was reviewed by experts in the
field prior to using it in this study.Conclusions
Reformulating PHVOs in India is technically and eco-
nomically feasible; however, there will be challenges in
terms of producing a product that meets consumer demand.
Ensuring that product reformulation is done in a way that
maximises health benefits will require shifts in knowledge
and subsequent demand of products, decreased reliance
on palm oil, investment in research and development
and increased capacity for smaller manufacturers. In
order to address these issues, we recommend that in-
dustry use different input oils depending on the given
product’s functionality requirements. We also recommend
that the government should require PHVO manufacturers
to use domestic oils, as has been previously done in India,
to increase uptake of PUFA use and provide support to
smaller companies through use of incentives given that
without support they will struggle to comply with regula-
tion. Lastly, it will be important for India to ensure that
the TFA limit in PHVOs is decreased from 10% to 5% (by
weight) after three years, as proposed in the regulation,
since industry will likely not adopt innovative technology
(i.e., interesterification and blending) that would allow
the use of PUFA with the limit of 10%, thereby decreas-
ing the potential health impact of the proposed regula-
tion. Continued monitoring of industry’s progress will
be essential.Abbreviations
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